The 0.1mm Revolution: MINISH Lands $22M to Reshape U.S. Dentistry

LOS ANGELES, CA – April 23, 2026 – Dental health-tech innovator MINISH Technology has secured a $22 million investment from private equity firm VIG Partners, catapulting its valuation to $110 million and signaling a major push into the American market. The deal, which gives VIG Partners a 20% minority stake, triples the company's 2023 valuation and provides the capital to accelerate its global expansion, bringing its enamel-preserving, biomimetic dental solutions to the United States.

The funding arrives as the dental industry experiences a significant paradigm shift. Patients and practitioners alike are increasingly moving away from aggressive, conventional cosmetic procedures toward minimally invasive alternatives that prioritize long-term tooth health. MINISH Technology has positioned itself at the forefront of this movement, championing a "No-Drill" philosophy that aims to restore teeth rather than simply redesign them.

A New Paradigm in Dental Preservation

At the heart of MINISH's approach is a rejection of the traditional veneer process, which often requires grinding down significant amounts of healthy tooth enamel—typically 0.5mm to 0.7mm—to fit porcelain shells. This irreversible procedure can lead to increased tooth sensitivity and compromise the tooth's structural integrity.

In contrast, MINISH Technology has developed an end-to-end clinical ecosystem built on biomimicry—the principle of emulating nature. The company uses proprietary nano-ceramic materials, known as "MINISH BLOCS," engineered to precisely match the physical properties of natural enamel, including its translucency, hardness, and wear resistance. Using advanced 3D scanning and 0.1mm precision milling, the company fabricates ultra-thin restorations that bond directly to the existing tooth structure.

This minimally invasive method, refined over 18 years and applied in what the company reports as more than 200,000 clinical cases, focuses on replacing only damaged or lost enamel. The result is a restoration that reinforces the natural tooth, often without the need for anesthesia, and preserves the vital enamel-to-enamel bond, which is critical for long-term durability. While some competitors offer "no-prep" veneers, MINISH differentiates itself with extensive clinical data and a 10-year warranty, underscoring its focus on restorative care over purely cosmetic enhancement.

The Strategic Bet on Health-Tech

The $110 million valuation is not just a reflection of MINISH's technological promise but also a calculated move by its new investor, VIG Partners. The Seoul-based private equity firm, which manages over $3.5 billion in capital, has recently shown a keen strategic interest in the burgeoning health, beauty, and aesthetics sectors. This investment follows VIG's acquisitions and investments in medical aesthetics device companies and pharmaceutical platforms, indicating a clear thesis on the growth potential of high-tech healthcare solutions.

The tripling of MINISH's valuation in just three years highlights strong market confidence in the shift towards biomimetic dentistry. The global cosmetic dentistry market is projected to expand significantly, reaching an estimated $65 billion by 2035. Within this booming industry, minimally invasive procedures represent one of the fastest-growing segments, driven by consumer demand for less discomfort, faster recovery, and health-centric outcomes. VIG's investment serves as a powerful endorsement of MINISH's potential to capture a significant share of this evolving market.

A Proven Global Blueprint for Education

Before setting its sights on the U.S., MINISH Technology honed its strategy in Asia, building a robust network of trained clinicians. The company’s expansion is fueled not just by its technology but by its comprehensive educational platform, the MINISH Academy. This approach ensures that dentists are equipped with the skills to implement the precise methodology correctly.

The international demand for this new standard of care was recently showcased at the 17th Global MINISH Veneers Training Course in Seoul. A cohort of 30 dentists and their assistants traveled from Japan for the intensive three-day masterclass. The program, led by CEO Dr. Jung-ho Kang and Dr. Sang-gil Lee, covered advanced diagnostics, digital workflows, and specialized bonding protocols. The course culminated in a live patient demonstration, providing tangible proof of the technique's real-world application and results.

Upon completion, the participants were welcomed into the Global MINISH Provider Network, a model the company intends to replicate worldwide. By exporting a complete clinical system—integrating technology, materials, and education—MINISH is creating a standardized, high-quality ecosystem rather than simply selling a product.

The California Launchpad and U.S. Market Entry

Building on its success in Asia, MINISH is now bringing its disruptive technology to the United States. The company has announced its first U.S. training course, scheduled for May 8-10, 2026, at the VITA North America Education Center in California. The course offers 20 CE credits and invites American dentists to join what MINISH calls the "shift towards health-first" veneer treatment.

The entry into the highly competitive U.S. market presents both significant opportunities and formidable challenges. The demand for restorative, minimally invasive dentistry is high, but MINISH will need to navigate a complex regulatory landscape, including securing FDA 510(k) clearance for its proprietary materials and integrated CAD/CAM system.

Furthermore, it will face established players in the dental materials market and must convince a new audience of clinicians to invest in its system and training. However, by leading with education and building a community of certified providers, MINISH aims to replicate its proven Asian strategy. As the company prepares to make its U.S. debut, the dental industry will be watching closely to see if this "0.1mm revolution" can deliver on its promise to preserve smiles and redefine restorative care across America.